BioAge Labs, Inc.
BioAge Labs, Inc. (BIOA) Revenue
Annual & quarterly revenue history · segment & region breakdown
BIOA · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBioAge Labs, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from $0.01B in FY2025.
Revenue trend
2025 – 2022 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.01B | +$0.01B | — |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BioAge Labs, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BioAge Labs, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from BioAge Labs, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BIOA revenue · 4 questionsBIOA's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from $0.01B in FY2025.
▸ Source: FMP · BioAge Labs, Inc. SEC filings · GAAP · BioAge Labs, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026